Addex Therapeutics Ltd

NASDAQ: ADXN · Real-Time Price · USD
8.00
0.48 (6.38%)
At close: Aug 15, 2025, 3:47 PM
7.94
-0.75%
After-hours: Aug 15, 2025, 04:00 PM EDT

Addex Therapeutics Ltd Income Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
170.62K 405.53K 557.48K 831.37K 1.35M 1.61M 2.05M 2.13M 1.69M 1.42M 1.23M 1.5M 2.31M 2.92M 4.34M 3.68M 3.55M
Cost of Revenue
n/a -90 1.55M 3.36M 5.23M 6.94M 20.01M 20.97M 24.84M 26.9M 25.1M 22.33M 20.32M 19.3M 9M 10.98M 9.57M
Gross Profit
170.62K 405.62K -988.78K -2.52M -3.88M -5.32M -17.96M -18.83M -23.15M -25.48M -23.87M -20.83M -18.01M -16.38M -4.66M -7.3M -6.02M
Operating Income
-2.57M -2.76M -4.99M -7.02M -8.67M -10.28M -11.1M -12.61M -17.16M -20.52M -21.3M -20.71M -18.12M -15.51M -13.11M -12.65M -11.12M
Interest Income
1.61K 9.18K 22.31K 35.87K 47.71K 63.96K 76.18K 66.13K 52.98K 29.25K 4.66K 2.29K 3.81K 532.87K 533.37K 533.41K 542.53K
Pretax Income
-5.65M -4.91M -6.58M -7.67M -8.88M -10.56M -11.35M -12.84M -17.39M -20.8M -21.58M -21.07M -18.54M -15.35M -13.05M -12.77M -11.19M
Net Income
8.67M 7.06M 5.4M 4.32M -11.24M -10.56M -11.35M -12.84M -17.39M -20.8M -21.58M -21.07M -18.54M -15.35M -13.05M -12.77M -11.19M
Selling & General & Admin
1.55M 1.88M 3.32M 4.74M 6.18M 7.2M 5.26M 5.9M 5.48M 5.92M 6.66M 5.74M 6.06M 5.14M 5.28M 5.09M 4.83M
Research & Development
288.66K 501.2K 961.74K 1.72M 2.28M 2.75M 8.04M 8.94M 13.94M 16.99M 14.75M 15.87M 13.86M 12.84M 14.4M 12.71M 11.3M
Other Expenses
902.31K 776.7K 583.91K 322.97K n/a 390.13K -1.02M -573.14K -576.23K -966.36K 445.35K -3.09K n/a n/a n/a n/a n/a
Operating Expenses
2.74M 3.16M 5.55M 7.85M 10.01M 11.89M 13.15M 14.75M 18.84M 21.94M 22.52M 22.21M 20.43M 18.42M 17.45M 16.34M 14.67M
Interest Expense
3.48K 3.55K 10.42K 13.33K 16.3K 16.3K 15.71K 18.59K 27.09K 48.9K 50.47K 54.08K 64.69K 63.01K 63.94K 66.49K 61.68K
Selling & Marketing Expenses
n/a 203.2K 203.2K 203.2K 203.2K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.74M 3.16M 5.55M 7.85M 10.02M 11.89M 13.15M 14.75M 18.84M 21.94M 22.52M 22.21M 20.43M 18.42M 17.45M 16.34M 14.67M
Income Tax Expense
n/a n/a 8.36K 11.86K 15.69K 73.71K 65.35K 61.85K 58.23K 300.00 9.64K 19.63K 42.37K 42.27K 43.2K 45.75K 40.94K
Shares Outstanding (Basic)
819.54K 815.2K 812.79K 812.79K 812.79K 793.64K 643.99K 601.57K 510.41K 497.46K 398.21K 312.23K 315.79K 289.81K 284.35K 283.83K 279.33K
Shares Outstanding (Diluted)
819.54K 815.2K 812.79K 812.79K 812.79K 793.64K 643.99K 601.57K 510.41K 497.46K 398.21K 312.23K 315.79K 289.81K 284.35K 283.83K 279.33K
EPS (Basic)
11.48 8.88 6.31 4.13 -15.6 -16.8 -20.4 -26.4 -45.6 -58.8 -67.2 -69.6 -63.6 -55.2 -49.2 -50.4 -48
EPS (Diluted)
11.04 8.44 6.31 4.13 -15.6 -16.8 -20.4 -26.4 -45.6 -58.8 -67.2 -69.6 -63.6 -55.2 -49.2 -50.4 -48
EBITDA
-5.45M -4.77M -6.37M -7.46M -8.71M -8.29M -9.09M -10.61M -15.14M -20.49M -21.26M -20.67M -18.13M -14.94M -12.64M -12.34M -10.76M
EBIT
-5.64M -4.91M -6.57M -7.65M -8.87M -8.5M -9.3M -10.79M -15.32M -20.76M -21.53M -21.01M -18.47M -15.29M -12.99M -12.7M -11.13M
Depreciation & Amortization
191.88K 192.7K 248.28K 270.09K 233.11K 305.95K 302.21K 304.15K 312.09K 323.14K 330.46K 340.88K 345.8K 347.61K 351.72K 362.99K 371.24K